RxDoctor Payments DataLook up a doctor →

Srini Hejeebu, DO

Internal Medicine · Toledo, OHNPI 1154316354

Payments from drug & device makers

$409,974in general payments, 2019–2025

Across 820 payments — averaging $499.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$347K
  • AstraZeneca$53K
  • Medtronic$8K
  • Novo Nordisk$438
  • Bayer$231
  • Johnson & Johnson$222
  • plus $487 from 6 others
$48in research payments, 2019–2025

Across 1 payment — averaging $48.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk$48

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$409,974 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$186,769
Medicare patients
332
Services billed
1,834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →